These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 12206099)
1. HLA B57 and abacavir hypersensitivity. Flexner C Hopkins HIV Rep; 2002 May; 14(3):5. PubMed ID: 12206099 [No Abstract] [Full Text] [Related]
2. Severe anaphylactic shock after rechallenge with abacavir without preceding hypersensitivity. Frissen PH; de Vries J; Weigel HM; Brinkman K AIDS; 2001 Jan; 15(2):289. PubMed ID: 11216946 [No Abstract] [Full Text] [Related]
3. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Hetherington S; Hughes AR; Mosteller M; Shortino D; Baker KL; Spreen W; Lai E; Davies K; Handley A; Dow DJ; Fling ME; Stocum M; Bowman C; Thurmond LM; Roses AD Lancet; 2002 Mar; 359(9312):1121-2. PubMed ID: 11943262 [TBL] [Abstract][Full Text] [Related]
4. Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity. Norcross MA; Luo S; Lu L; Boyne MT; Gomarteli M; Rennels AD; Woodcock J; Margulies DH; McMurtrey C; Vernon S; Hildebrand WH; Buchli R AIDS; 2012 Jul; 26(11):F21-9. PubMed ID: 22617051 [TBL] [Abstract][Full Text] [Related]
5. 1592 (abacavir): do not rechallenge after hypersensitivity reaction. James JS AIDS Treat News; 1997 Dec; (No 285):1, 5. PubMed ID: 11364916 [TBL] [Abstract][Full Text] [Related]
6. A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome. Martin AM; Krueger R; Almeida CA; Nolan D; Phillips E; Mallal S Pharmacogenet Genomics; 2006 May; 16(5):353-7. PubMed ID: 16609367 [TBL] [Abstract][Full Text] [Related]
7. A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase. Chui CK; Brumme ZL; Brumme CJ; Yip B; Phillips EJ; Montaner JS; Harrigan PR Clin Infect Dis; 2007 Jun; 44(11):1503-8. PubMed ID: 17479950 [TBL] [Abstract][Full Text] [Related]
8. [Correlation, in previously treated HIV-1 positive patients, between hypersensitivity reaction to abacavir and the presence of the HLA-B*5701 allele]. Pérez Prior N; Rocher Milla A; Soler Company E; Flores Cid J; Sarria Chust B Farm Hosp; 2009; 33(3):155-60. PubMed ID: 19712599 [TBL] [Abstract][Full Text] [Related]
9. Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experience. Waters LJ; Mandalia S; Gazzard B; Nelson M AIDS; 2007 Nov; 21(18):2533-4. PubMed ID: 18025891 [TBL] [Abstract][Full Text] [Related]
12. Abacavir (Ziagen(®)) use between 2003 and 2008 in France according to the electronic medical record NADIS(®). Dellamonica P; Katlama C; Lévy-Bachelot L; Daures JP; Finkielsztejn L Med Mal Infect; 2013 Dec; 43(11-12):467-74. PubMed ID: 24262915 [TBL] [Abstract][Full Text] [Related]
13. Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy. CNA2001 Investigative Group. Harrigan PR; Stone C; Griffin P; Nájera I; Bloor S; Kemp S; Tisdale M; Larder B J Infect Dis; 2000 Mar; 181(3):912-20. PubMed ID: 10720512 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive evaluation of two HLA-B17 monoclonal antibodies for flow cytometry-based HLA-B57/B58 screening prior to abacavir prescription. Stevens R; Coates E; Street J; Cook E; Darke C Int J Immunogenet; 2013 Aug; 40(4):311-5. PubMed ID: 23280011 [TBL] [Abstract][Full Text] [Related]
15. Severe abacavir hypersensitivity reaction in a patient tested HLA-B*5701 negative. Bonta PI; Vermeulen JN; Speelman P; Prins JM AIDS; 2008 Jul; 22(12):1522-3. PubMed ID: 18614879 [No Abstract] [Full Text] [Related]
16. Current trends in screening across ethnicities for hypersensitivity to abacavir. Rodriguez-Nóvoa S; Soriano V Pharmacogenomics; 2008 Oct; 9(10):1531-41. PubMed ID: 18855539 [TBL] [Abstract][Full Text] [Related]
17. Heart attack risk with abacavir and didanosine. AIDS Patient Care STDS; 2008 Apr; 22(4):346-7. PubMed ID: 18434947 [No Abstract] [Full Text] [Related]
18. Cytokine profiling in abacavir hypersensitivity patients. Almeida CA; Martin AM; Nolan D; Lucas A; Cameron PU; James I; Phillips E; Mallal S Antivir Ther; 2008; 13(2):281-8. PubMed ID: 18505179 [TBL] [Abstract][Full Text] [Related]
19. Chronic cough induced by abacavir apart from a context of hypersensitivity. Peyrière H; Mauboussin JM; Arnaud A; Rouanet I; Vincent D Allerg Immunol (Paris); 2002 Dec; 34(10):359-60. PubMed ID: 12575618 [TBL] [Abstract][Full Text] [Related]
20. Should HLA-B*5701 screening be performed in every ethnic group before starting abacavir? Park WB; Choe PG; Song KH; Lee S; Jang HC; Jeon JH; Park SW; Park MH; Oh MD; Choe KW Clin Infect Dis; 2009 Feb; 48(3):365-7. PubMed ID: 19115972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]